Submit Deal
All corporates
Similar corporates
Summary
Bird Rock Bio is a clinical stage biopharmaceutical company focused on developing innovative immuno-inflammatory regulators.
Deals Overview
Market Context
All Corporates
Back to top
All rights reserved. Copyright © 2025 Datasite
Senior Management
Paul Grayson
CEO
Alyssa Lochbaum
CFO
Deals (1)
Service Providers
Relationships
Portfolio
Team
Sort
Target: BIRD ROCK BIO
Bidder: SKYE BIOSCIENCE
4 Service Providers
19 Dealmakers
£ 15 M
Value
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy